(DSS) DSS - Ratings and Ratios
Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US26253C1027
DSS: Packaging, Biotech, Finance, Securities, Lending, Healthcare
DSS Inc. (NYSE MKT:DSS), formerly known as Document Security Systems, Inc., is a diversified company operating across multiple sectors. The company specializes in product packaging, offering eco-friendly mailers, photo sleeves, custom folding cartons, and innovative 3-dimensional direct mail solutions. Additionally, DSS distributes nutritional and personal care products, emphasizing wellness. In the biotechnology sector, DSS invests in biohealth and biomedical companies, focusing on drug discovery and the treatment of neurological, oncological, and immune-related diseases. They are also pioneering open-air defense initiatives against airborne diseases like tuberculosis and influenza.
DSS further extends its reach into financial services by acquiring stakes in undervalued commercial banks, bank holding companies, and non-banking financial institutions. The company provides a range of financial services, including loan syndication, mortgage banking, trust and escrow services, and problem asset management. DSS also operates a real estate investment trust focused on healthcare properties. In the securities arena, they engage in investment management, securities trading, and digital asset brokerage. Despite their diverse operations, DSS faces challenges, as indicated by a negative Return on Equity of -85.07%, reflecting profitability struggles.
3-Month Forecast: - Technical Outlook: DSS shares are trading below their 20 and 50-day Simple Moving Averages (SMA) at 0.91 and 0.90, respectively, but above the 200-day SMA of 1.25. This indicates potential near-term weakness but longer-term support. The Average True Range (ATR) of 0.06 signals low volatility, suggesting price stability. - Fundamental Outlook: With a Price-to-Book (P/B) ratio of 0.15 and a negative Price-to-Earnings (P/E) ratio, DSS appears undervalued. However, the negative Return on Equity (RoE) of -85.07% raises concerns about profitability. The low average volume of 9,669 shares suggests limited market activity, which could impact liquidity. Conclusion: Over the next three months, DSS is expected to experience sideways trading with potential slight downside due to poor earnings and limited market activity. Investors should closely monitor the companys profitability improvements and market participation.Additional Sources for DSS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DSS Stock Overview
Market Cap in USD | 9m |
Sector | Consumer Cyclical |
Industry | Packaging & Containers |
GiC Sub-Industry | Commercial Printing |
IPO / Inception | 1997-01-03 |
DSS Stock Ratings
Growth Rating | -93.4 |
Fundamental | -65.2 |
Dividend Rating | 0.0 |
Rel. Strength | -48.6 |
Analysts | 5/5 |
Fair Price Momentum | 0.36 USD |
Fair Price DCF | - |
DSS Dividends
No Dividends PaidDSS Growth Ratios
Growth Correlation 3m | 38.4% |
Growth Correlation 12m | -91.7% |
Growth Correlation 5y | -98.7% |
CAGR 5y | -65.26% |
CAGR/Max DD 5y | -0.66 |
Sharpe Ratio 12m | -1.45 |
Alpha | -49.01 |
Beta | -0.033 |
Volatility | 60.54% |
Current Volume | 2.7k |
Average Volume 20d | 6.1k |
As of April 30, 2025, the stock is trading at USD 0.96 with a total of 2,666 shares traded.
Over the past week, the price has changed by +2.39%, over one month by +11.00%, over three months by +18.83% and over the past year by -45.00%.
No, based on ValueRay Fundamental Analyses, DSS (NYSE MKT:DSS) is currently (April 2025) a stock to sell. It has a ValueRay Fundamental Rating of -65.18 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DSS as of April 2025 is 0.36. This means that DSS is currently overvalued and has a potential downside of -62.5%.
DSS has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy DSS.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DSS DSS will be worth about 0.4 in April 2026. The stock is currently trading at 0.96. This means that the stock has a potential downside of -59.38%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 27.6 | 2775% |
Analysts Target Price | 1.5 | 56.3% |
ValueRay Target Price | 0.4 | -59.4% |